Human papillomavirus type 16 variant analysis of E6, E7, and L1 genes and long control region in biopsy samples from cervical cancer patients in north India - PubMed (original) (raw)
Human papillomavirus type 16 variant analysis of E6, E7, and L1 genes and long control region in biopsy samples from cervical cancer patients in north India
Shailja Pande et al. J Clin Microbiol. 2008 Mar.
Abstract
High-risk human papillomaviruses (HPVs), particularly HPV types 16 and 18 (HPV-16 and HPV-18, respectively), play a cardinal role in the etiology of cervical cancer. The most prevalent type, HPV-16, shows intratypic sequence variants that are known to differ in oncogenic potential and geographic distribution. This study was designed to analyze sequence variations in E6, E7, and L1 genes and the LCR (for long control region) of HPV-16 in cervical cancer patients to identify the most prevalent and novel HPV-16 variants and to correlate them with the severity of the disease. Cervical biopsies from 60 HPV-16-positive cancer cases were analyzed by PCR and DNA sequencing. The most frequently observed variations were T350G (100%) in E6, T789C (87.5%) in E7, A6695C (54.5%) in L1, and G7521A (91.1%) in the LCR. In addition, only one novel variant (T527A) in E6 and four new variants each in L1 (A6667C, A6691G, C6906T, and A6924C) and in the LCR (C13T, A7636C, C7678T, and G7799A) were identified. While E7 was found to be highly conserved, the variant 350G of E6 was the most prevalent in all of the histopathological grades. The majority of LCR variants were found at the YY1 transcription factor binding sites. Interestingly, a complete absence of the Asian lineage and a high prevalence of European lineages in E6, E7, L1, and the LCR (85, 86.7, 67.7, and 63.3%, respectively) indicate a possible epidemiological linkage between Europe and India with regard to the dissemination of HPV-16 infections in India.
Figures
FIG. 1.
Sequencing electropherogram showing frequently detected nucleotide variations in different genomic segments of HPV-16. (a) E6 T350G; (b) E7 T789C; (c) L1 A6695C; and (d) LCR G7521A. The upper panel shows prototype sequences, while the lower panel shows variant sequences (indicated by arrows).
FIG. 2.
Nucleotide sequence variations among the HPV-16 isolates. The nucleotide positions of E6, E7, the LCR, and L1 at which variations were observed are written across the top. The identification codes of the samples are indicated on the left. REF, the HPV-16 reference DNA sequence. For each variant sequence, positions that do not vary from those of the HPV reference sequence are marked with dashes.
Similar articles
- Variations of human papillomavirus type 58 E6, E7, L1 genes and long control region in strains from women with cervical lesions in Liaoning province, China.
Liu JH, Lu ZT, Wang GL, Zhou WQ, Liu C, Yang LX, Sun ZR, Ruan Q. Liu JH, et al. Infect Genet Evol. 2012 Oct;12(7):1466-72. doi: 10.1016/j.meegid.2012.05.004. Epub 2012 May 29. Infect Genet Evol. 2012. PMID: 22659102 - Human papillomavirus type 16 variant analysis of E6, E7, and L1 [corrected] genes and long control region in [corrected] cervical carcinomas in patients in northeast China.
Shang Q, Wang Y, Fang Y, Wei L, Chen S, Sun Y, Li B, Zhang F, Gu H. Shang Q, et al. J Clin Microbiol. 2011 Jul;49(7):2656-63. doi: 10.1128/JCM.02203-10. Epub 2011 May 18. J Clin Microbiol. 2011. PMID: 21593270 Free PMC article. - Molecular variants of HPV-16 associated with cervical cancer in Indian population.
Pillai MR, Hariharan R, Babu JM, Lakshmi S, Chiplunkar SV, Patkar M, Tongaonkar H, Dinshaw K, Jayshree RS, Reddy BK, Siddiqui M, Roychoudury S, Saha B, Abraham P, Gnanamony M, Peedicayil A, Subhashini J, Ram TS, Dey B, Sharma C, Jain SK, Singh N. Pillai MR, et al. Int J Cancer. 2009 Jul 1;125(1):91-103. doi: 10.1002/ijc.24322. Int J Cancer. 2009. PMID: 19358280 - Cervical human papillomavirus screening by PCR: advantages of targeting the E6/E7 region.
Morris BJ. Morris BJ. Clin Chem Lab Med. 2005;43(11):1171-7. doi: 10.1515/CCLM.2005.203. Clin Chem Lab Med. 2005. PMID: 16232081 Review. - [Molecular basis of cervical carcinogenesis by high-risk human papillomaviruses].
Yugawa T, Kiyono T. Yugawa T, et al. Uirusu. 2008 Dec;58(2):141-54. doi: 10.2222/jsv.58.141. Uirusu. 2008. PMID: 19374192 Review. Japanese.
Cited by
- HPV DNA status and clinical history of patients are supplements for accurate reporting of the cytological Pap smear.
Ali M, Sinha R, Kumar A, Karim S, Irfan M, Kumar S, Sinha S, Kumar A, Ghosh A, Singh M. Ali M, et al. Sci Rep. 2024 Jul 30;14(1):17486. doi: 10.1038/s41598-024-68344-4. Sci Rep. 2024. PMID: 39080413 Free PMC article. - Genetic variation of E6 and E7 genes of human papillomavirus type 16 from central China.
Li T, Yang Z, Zhang C, Wang S, Mei B. Li T, et al. Virol J. 2023 Sep 27;20(1):217. doi: 10.1186/s12985-023-02188-8. Virol J. 2023. PMID: 37759219 Free PMC article. - Distribution of Human Papillomavirus Genotypes among the Women of South Andaman Island, India.
Parvez R, Vijayachari P, Saha MK, Biswas L, Ramasamy J, Vins A, Beniwal N, Vasanthi S, Ramadoss S, Kaur H, Nagarajan M. Parvez R, et al. Diagnostics (Basel). 2023 Aug 25;13(17):2765. doi: 10.3390/diagnostics13172765. Diagnostics (Basel). 2023. PMID: 37685303 Free PMC article. - Type distribution of human papillomaviruses in ThinPrep cytology samples and HPV16/18 E6 gene variations in FFPE cervical cancer specimens in Fars province, Iran.
Farhadi A, Abuei H, Okhovat MA, Geramizadeh B, Behzad-Behbahani A, Chong PP, Nikouyan N, Namdari S. Farhadi A, et al. Cancer Cell Int. 2023 Aug 11;23(1):166. doi: 10.1186/s12935-023-03011-8. Cancer Cell Int. 2023. PMID: 37568237 Free PMC article. - Genotypic distribution of human papillomavirus and phylogenetic analysis of E6 and E7 gene of HR-HPV variants isolated from Pakistani population.
Ahmed S, Vajeeha A, Idrees M, Hussain A, Munir R, Zaidi G, Zahid K, Ahmed R, Fatima Z, Rafique S, Achakzai NM. Ahmed S, et al. Medicine (Baltimore). 2023 Jan 13;102(2):e32651. doi: 10.1097/MD.0000000000032651. Medicine (Baltimore). 2023. PMID: 36637937 Free PMC article.
References
- Bernard, H. U., S. Y. Chan, M. M. Manos, C. K. Ong, L. L. Villa, H. Delius, C. L. Peyton, H. M. Bauer, and C. M. Wheeler. 1994. Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. J. Infect. Dis. 1701077-1085. - PubMed
- Bontkes, H. J., M. van Duin, T. D. de Gruijl, M. F. Duggan-Keen, J. M. Walboomers, M. J. Stukart, R. H. Verheijen, T. J. Helmerhorst, C. J. Meijer, R. J. Scheper, F. R. Stevens, P. A. Dyer, P. Sinnott, and P. L. Stern. 1998. HPV 16 infection and progression of cervical intra-epithelial neoplasia: analysis of HLA polymorphism and HPV 16 E6 sequence variants. Int. J. Cancer 78166-171. - PubMed
- Castle, P. E., M. Schiffman, R. Herrero, A. Hildesheim, A. C. Rodriguez, M. C. Bratti, M. E. Sherman, S. Wacholder, R. Tarone, and R. D. Burk. 2005. A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica. J. Infect. Dis. 1911808-1816. - PubMed
- Crook, T., J. A. Tidy, and K. H. Vousden. 1991. Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation. Cell 67547-556. - PubMed